Symptomatic intracerebral hematomas in posterior circulation stroke patients anticoagulated with heparin

Journal of Thrombosis and Thrombolysis

Volumn 21, Issue 3, 2006, Pages 249-255

  Kang, Kyusik ^a,b   Yoon, Byung Woo ^a  

^a Seoul National University Hospital   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Anticoagulation; Diffusion weighted imaging; Heparin; Posterior circulation stroke

Indexed keywords

HEPARIN; WARFARIN;

ADULT; AGE; AGED; BRAIN CIRCULATION; BRAIN HEMATOMA; BRAIN INFARCTION SIZE; BRAIN SCINTISCANNING; CEREBELLUM; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; DRUG CONTRAINDICATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LEUKOARAIOSIS; MALE; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYMPTOM;

AGED; AGED, 80 AND OVER; BRAIN; BRAIN INFARCTION; CEREBELLUM; CEREBRAL HEMORRHAGE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HEMATOMA; HEPARIN; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 33646433764     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-6967-5     Document Type: Review

References (40)

1. Millikan CH (1971) Reassessment of anticoagulation therapy in various type of occlusive cerebrovascular disease. Stroke 2:201-208
2. Millikan CH, Siekert RG, Shick RM (1955) Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Mayo Clin Proc 30:116-126
3. Millikan CG, Siekert RG, Whisnant JP (1958) Anticoagulant therapy in cerebrovascular disease: Current status. JAMA 166:587-592
4. Siekert RG, Whisnant JP, Millikan CH (1963) Surgical and anticoagulant therapy of occlusive cerebrovascular disease. Ann Intern Med 58:637-641
5. Whisnant JP (1961) Discussion. In: Millikan C, Siekert R, Whisnant JP (eds.) Cerebral vascular diseases: Third princeton conference on cerebrovascular diseases. Orlando, Fla, Grune & Stratton, pp. 156-157
6. Al-Sadat A, Sunbulli M, Chaturvedi S (2002) Use of intravenous heparin by North American neurologists: Do the data matter? Stroke 33:1574-1577
7. Tettenborn B (2001) Extended infarcts in the posterior circulation (brainstem/cerebellum). In: Bogousslavsky J, Caplan LR (eds.) Stroke Syndromes, 2nd edition Cambridge, Cambridge University Press, pp. 557-563
8. Caplan L (2000) Posterior circulation ischemia: Then, now, and tomorrow. The Thomas Willis Lecture-2000. Stroke 31:2011-2023
9. Victor M, Ropper AH (2001) Cerebrovascular diseases. In: Adams and Victor's principles of neurology, 7th edn. McGraw-Hill, New York, 821-924
10. Misra M, Alp MS, Hier D, Ausman JI (2004) Multidisciplinary treatment of posterior circulation ischemia. Neurol Res 26:67-73
11. Al-Sadat A, Sunbulli M, Chaturvedi S (2002) Use of intravenous heparin by North American neurologists: Do the data matter? Stroke 33:1574-1577
12. Yoon SS, Heo SH, Park KC, et al. (2005) The Usage of Intravenous Heparin in Acute Ischemic Stroke in 10 Teaching Hospitals. Journal of the Korean Neurological Association 23:446-450
13. Adams H, Adams R, Del Zoppo G, Goldstein LB (2005) Stroke Council of the American Heart Association; American Stroke Association. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 36:916-923
14. International Stroke Trial Collaboration Group (1997). The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute stroke. Lancet 349:1569-1581
15. Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ (1988) Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19:1216-1222
16. Cerebral embolism study group (1983). Immediate anticoagulation of embolic stroke: A randomized trial. Stroke 14:668-676
17. Calander L, Ortega JF, Berbejo F, Portera A (1983) Cerebral embolism and anticoagulation. (Letter to the editor) Neurology 33:1103-1106
18. Chamorro A, Vila N, Saiz A, Alday M, Tolosa E (1995) Early anticoagulation after large cerebral embolic infarction: A safety study. Neurology 45:861-865
19. Chamorro A, Vila N, Ascaso C, Blanc R (1999) Heparin in acute stroke with atrial fibrillation. Clinical relevance of very early treatment. Arch Neurol 56:1098-1102
20. Camerlingo M, Casto L, Censori B, et al. (1994) Immediate anticoagulation with heparin for first-ever ischemic stroke in the carotid artery territories observed within 5 hours of onset. Arch Neurol 51:462-467
21. Cerebral embolism study group (1987). Cardioembolic stroke, early anticoagulation, and brain hemorrhage. Arch Intern Med 147:636-640
22. Cerebral embolism study group (1984). Immediate anticoagulation of embolic stroke: Brain hemorrhage and management options. Stroke 15:779-789
23. Glass TA, Hennessey PM, Pazdera L, et al. (2002) Outcome at 30 days in the New England Medical Center Posterior Circulation Registry. Arch Neurol 59:369-376
24. Kim HJ, Cho HI, Lee DS (2000) Should therapeutic range in heparin therapy be changed with new reagent for activated partial thromboplastin time? Korean J. Med. 59:505-510
25. Hornig CR, Bauer T, Simon C, Trittmacher S, Dorndorf W (1993) Hemorrhagic transformation in cardioembolic cerebral infarction. Stroke 24:465-468
26. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR 149:351-356
27. Kase CS, Robinson RK, Stein RW, et al. (1985) Anticoagulant-related intracerebral hemorrhage. Neurology 35:943-948
28. Radberg JA, Olsson JE, Radberg CT (1991) Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 22:571-576
29. Brandt T, von Kummer R, Muller-Kuppers M, Hacke W (1996) Thrombolytic therapy of acute basilar artery occlusion variables affecting recanalization and outcome. Stroke 27:875-881
30. Hornig CR, Buttner T, Hoffmann O, Dorndorf W (1992) Short-term prognosis of vertebrobasilar ischemic stroke. Cerebrovasc Dis 2:273-281
31. Lutsep HL, Albers GW, DeCrespigny A, Kamat GN, Marks MP, Moseley ME (1997) Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 41:574-580
32. Fennerty AG, Renowden S, Scolding N, Bentley DP, Campbell IA, Routledge PA (1986) Guidelines to control heparin treatment. Brit Med J 292:579-580
33. Elliott GC, Hiltunen SJ, Suchyta M, et al. (1994) Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Arch Intern Med 154:999-1004
34. Cory Toth, Chris Voll (2002) Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke. Stroke 33:670-674
35. Barnes C, Blanchette V, Canning P, Carcao M (2005) Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment. Transfus Med 15:145-150
36. Nilsson OG, Lindgren A, Stahl N, Brandt L, Saveland H (2000) Incidence of intracerebral and subarachoid hemorrhage in southern Sweden. J Neurol Neurosurg Psych 69:601-607
37. Tanaka H, Ueda Y, Date C, et al. (1981) Incidence of stroke in Shibata, Japan, 1976-1978, Stroke 12:460-466
38. Tanaka A, Ueno Y, Nakayama Y, Takano K, Takebayashi S. (1999) Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke 30:1637-1642
39. Kang K, Lee YS, Kim NH, Kim DE, Park SH (2003) Associated ischemic lesions in intracranial hemorrhage: MRI study. Eur Neurol 49:94-97
40. Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM (2002) Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 59:193-197